HealthcareServices

Global Specimen Validity Testing Market 2025–2029: Competitive Insights and Opportunities

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Specimen Validity Testing Industry Expected To Reach By 2029, Starting From 2025 Levels?

The specimen validity testing market has experienced significant expansion in recent years. It is anticipated to grow from $3.68 billion in 2024 to $4.03 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to factors such as increasing drug adoption, increased drug screening, stringent regulations, a rise in alcohol use, and the integration of point-of-care testing.

The specimen validity testing market size is projected to experience substantial growth over the coming years. This market is anticipated to reach $5.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.6%. The expansion during this forecast period is attributed to the increasing demand for workplace drug testing, the growing adoption of oral fluid testing, an escalation in research and development operations, the rising usage of SVT, and broadening applications in pain management. Significant trends within the forecast period encompass technological advancements, the integration of artificial intelligence for result interpretation, product innovations, an increase in partnerships, and the development of portable testing devices for convenient, on-the-go monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp

What Are The Key Drivers Of Growth In The Specimen Validity Testing Market?

The rising prevalence of drug abuse is projected to drive the growth of the specimen validity testing market in the future. Drug abuse is characterized as the habitual, excessive, or inappropriate consumption of legal or illegal substances for non-medical reasons. This increase in drug abuse is attributed to several interconnected factors, including the opioid epidemic, emerging mental health conditions, limitations in treatment and support resources, and cultural influences. Specimen Validity Testing (SVT) methods are developed to identify impurities and compounds by analyzing various parameters such as pH, specific gravity, creatinine content, and temperature. For instance, in October 2023, the Office for Health Improvement and Disparities, a UK-based government department, reported that adult interactions with drug and alcohol programs climbed to 0.29 million between April 2021 and March 2022, up from 0.28 million in the previous year. Additionally, in October 2024, the Office for National Statistics, a UK-based government agency, indicated that England and Wales registered 5,448 drug poisoning-related deaths in 2023, an 11.0% increase from the 4,907 deaths recorded in 2022. Hence, the growing issue of drug abuse is expected to significantly boost the specimen validity testing market.

What Are The Major Segments Identified In The Specimen Validity Testing Market?

The specimen validity testingmarket covered in this report is segmented –

1) By Product And Service: Products; Service

2) By Testing Type: Laboratory Testing; Rapid Or Point-Of-Care Testing

3) By End-User: Drug Rehabilitation Centers; Drug Screening Laboratories; Pain Management Centers; Criminal Justice And Law Enforcement Agencies; Other End-Users

Subsegments:

1) By Products: Reagents And Assay Kits; Controls And Calibrators; Specimen Collection Devices; Analyzers And Instruments

2) By Service: Laboratory Testing Services; Point-Of-Care Testing Services

How Are Emerging Market Trends Shaping The Specimen Validity Testing Industry Landscape?

Major companies operating in the specimen validity testing market are creating innovative products, such as high-resolution urine drug testing profiles, to secure their standing. A high-resolution urine drug testing profile is an advanced method utilizing sophisticated analytical techniques. For instance, in July 2022, Mayo Clinic Laboratories, a US-based medical laboratory, introduced a data-driven urine drug testing (UDT) profile aimed at providing physicians with essential data for managing patients with addiction to common substances like prescription opioids, alcohol, marijuana, and nicotine. This new addiction medicine monitoring profile (Mayo ID ADMPU) adheres to the American Society of Addiction Medicine’s guidelines and offers improved sensitivity and specificity for identifying parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. The profile employs high-resolution, accurate mass spectrometry for targeted analysis and immunoassay testing for specific substances, delivering thorough and clinically useful information for healthcare providers.

Which Global Market Leaders Are Shaping The Future Of The Specimen Validity Testing Sector?

Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Which Regional Markets Are Contributing Most To The Specimen Validity Testing Industry Expansion?

North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Specimen Validity Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15673&type=smp

Browse Through More Reports Similar to the Global Specimen Validity Testing Market 2025, By The Business Research Company

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Pharma Microbiology Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

Non Invasive Prenatal Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795